Dermatol. praxi. 2016;10(4):197-200 | DOI: 10.36290/der.2016.044

The first case of nitrofurantoin-induced toxic epidermal necrolysis?

MUDr. Břetislav Lipový, Ph.D.1,2, MUDr. Hana Řihová1, MUDr. Michaela Wilková1,2, MUDr. Markéta Hanslianová3, MUDr. Jitka Kyclová4, prof. MUDr. Pavel Brychta, CSc.1,2
1 Klinika popálenin a rekonstrukční chirurgie FN Brno
2 Lékařská fakulta Masarykovy univerzity Brno
3 Oddělení klinické mikrobiologie FN Brno
4 Ústav patologie FN Brno

Nitrofurantoin has experienced a significant renaissance in use in the past decade. This is particularly due to the increasing resistance of potentially pathogenic microorganisms causing urinary tract infection. Toxic epidermal necrolysis represents an escalated allergic reaction that is predominantly manifested by extensive exfoliation in the area of the skin and mucosae. In the majority of cases, this condition is brought about by the use of some of the medications. Currently, there are over 150 products which are known to be capable of inducing the development of toxic epidermal necrolysis. Despite a thorough analysis of available databases (Pubmed, Scopus, Web of Science), we have failed to find a single case report that would describe the development of this syndrome following the use of nitrofurantoin.

Keywords: toxic epidermal necrolysis, nitrofurantoin

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lipový B, Řihová H, Wilková M, Hanslianová M, Kyclová J, Brychta P. The first case of nitrofurantoin-induced toxic epidermal necrolysis? Dermatol. praxi. 2016;10(4):197-200. doi: 10.36290/der.2016.044.
Download citation

References

  1. Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J, Roujeau JC. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol. 1996; 134(4): 710-714. Go to original source... Go to PubMed...
  2. Polifka M, Krusinski PA. The Nikolsky sign. Cutis. 1980; 26(5): 521-525, 526. Go to original source... Go to PubMed...
  3. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008; 128(1): 35-44. Epub 2007 Sep 6. Go to original source... Go to PubMed...
  4. Gomulka J, Wilson BD, Joyce JC. Toxic epidermal necrolysis due to voriconazole: case report and review. Dermatol Online J. 2014 Sep 16;20(9). pii: 13030/qt2pt32578. Review. Go to original source...
  5. Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013; 169(5): 1071-1080. doi: 10.1111/bjd.12501. Go to original source... Go to PubMed...
  6. Kashanian J, Hakimian P, Blute M Jr, Wong J, Khanna H, Wise G, Shabsigh R. Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int. 2008; 102(11): 1634-1637. doi: 10.1111/j.1464-410X.2008.07809.x. Epub 2008 Jul 24. Go to original source... Go to PubMed...
  7. McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994; 33 Suppl A: 23-30. Go to original source... Go to PubMed...
  8. Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015; 70(9): 2456-2464. doi: 10.1093/jac/dkv147. Epub 2015 Jun 11. Go to original source... Go to PubMed...
  9. Chapman JA. An unusual nitrofurantoin-induced drug reaction. Ann Allergy. 1986; 56(1): 16-18.
  10. Fitzgerald DA, Smith AG, Suarez V, Daggett PR. Stevens-Johnson syndrome and toxic hepatitis induced by nitrofurantoin: a case report. J Dermatol Treat 1993; 4: 211-213. Go to original source...
  11. Velema MS, Voerman HJ. DRESS syndrome caused by nitrofurantoin. Neth J Med. 2009; 67(4): 147-149.
  12. Le?o RN, Barreto P, Le?o RR, Ribeiro JV. Nitrofurantoin: cause of DRESS syndrome. BMJ Case Rep. 2013 May 8;2013. pii: bcr2013008991. doi: 10.1136/bcr-2013-008991. Go to original source... Go to PubMed...
  13. Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol. 1990 Jan;126(1):43-7. Go to original source... Go to PubMed...
  14. MedsFacts. Philadelphia PA.Study of possible correlation between TOXIC EPIDERMAL NECROLYSIS and NITROFURANTOIN. Available from: http://drugline.se/questions/en/23370/?query=mesh:%22nitrofurantoin%20-%20AE%22.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.